Bold Debates on the Future of Thrombectomy in Stroke: ESOC 2025
European Stroke Organisation (ESO) shared an insightful post on X:
”Couldn’t attend live? Explore one of the key discussions from Day 2 at ESOC 2025 in Helsinki. Our guests debate large core trial results: Are questions still open? Should thrombectomy be for all?”
Watch the key discussions here.
At ESOC 2025 in Helsinki, one of the key discussions on Day 2 centered on the evolving evidence from large core stroke trials.
Experts Anne Hege Nymoen Aamodt and Götz Thomalla debated whether current results fully address the complexities of patient selection and whether thrombectomy should be expanded to all patients.
The session highlighted ongoing uncertainties and the need for further research to refine treatment strategies in this challenging stroke population.
Do not miss the latest updates on global discussions, stay tuned with Hemostasis Today.
-
May 23, 2026, 03:55WFH Initiative Brings Hope to the Hemophilia Community in India
-
May 23, 2026, 03:47Satyam Arora: Welcoming the New ISBT Board for the 2026 Term
-
May 23, 2026, 03:33Brig Tathagata Chatterjee: Connecting With World Leaders in Hematology at ISH Congress
-
May 23, 2026, 03:18Mathangi Kumar: Dental Management Strategies for Congenital Hemophilia
-
May 23, 2026, 03:02Maitri Vaishnav: Anatomical Variability and Surgical Relevance of Corona Mortis
-
May 23, 2026, 02:26Muhammad Hashim: When the Blood Smear Told a Different Story Behind a ‘Critical’ Platelet Count
-
May 23, 2026, 02:20Augustina Isioma Ikusemoro: Understanding One of the Most Common and Preventable Transfusion Reactions
-
May 23, 2026, 02:15What’s Your Advice for the Newly Diagnosed? – ITP Support Association
-
May 23, 2026, 02:08Rob Maloney: When You Stop Building Only a Career and Start Building a Life of Significance